KaydedilenlerDerginizi ekleyin

Dergiler / Erciyes Medical Journal / 2022 / Cilt: 44 - Sayı: 3

Pituitary Insufficiency Diagnosed After Coronavirus Disease-19: A Case Report

Mina Gülfem KAYA
Cem ERTÜRK
Muhammet GÜVEN
Sayfa
347–349
Yayın Tarihi
2022-10-11
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

Physicians should be aware about the systemic effects of SARS-CoV-2 infection and follow-up patients with a history of COVID-19 accordingly.

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:Background: Severe acute respiratory syndrome-coronavirus (SARS-CoV) and SARS-CoV-2 might affect the hypothalamic- pituitary-adrenal axis.
📊
Temel Bulgular & Veri:This paper presents a rare case of pituitary insufficiency diagnosed after CoV disease (COVID)-19.
💡
Sonuç & Katkı:Physicians should be aware about the systemic effects of SARS-CoV-2 infection and follow-up patients with a history of COVID-19 accordingly.
🔬Tür:Deneysel Tarla Denemesi
📍Kapsam:2020 Verileri
⚙️Değişkenler:Alan Parametreleri

Abstract

Background: Severe acute respiratory syndrome-coronavirus (SARS-CoV) and SARS-CoV-2 might affect the hypothalamic- pituitary-adrenal axis. This paper presents a rare case of pituitary insufficiency diagnosed after CoV disease (COVID)-19. Case Report: On December 7, 2020, a 67-year-old male patient presented to the Endocrinology Department of Lokman Hekim University with weakness, weight loss, and abdominal pain lasting for 3 weeks. In his medical history, he had a positive real-time polymerase chain reaction test result for SARS-CoV-2 based on the nasopharyngeal swab analyzed on September 30. Central hypothyroidism, secondary adrenal insufficiency, hypogonadotropic hypogonadism, and a low dehydroepiandrosterone- sulfate level were detected in the laboratory examinations. Steroid therapy was initiated. Conclusion: Non-specific adrenal insufficiency symptoms such as fatigue and weakness, and psychosomatic symptoms can be seen during the course of COVID-19 or the post-COVID-19 period. Physicians should be aware about the systemic effects of SARS-CoV-2 infection and follow-up patients with a history of COVID-19 accordingly.

🔖

Bu Makaleye Atıf Yap

KAYA, M. G., ERTÜRK, C., GÜVEN, M. (2022). Pituitary Insufficiency Diagnosed After Coronavirus Disease-19: A Case Report. Erciyes Medical Journal, Cilt: 44 - Sayı: 3, 347–349. https://ajindex.com/articles/502125

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (7)

  1. Li X, Geng M, Peng Y, Meng L, Lu S. Molecular immune pathogenesis and diagnosis of COVID-19. J Pharm Anal 2020; 10(2): 102–8
  2. Leow MK, Kwek DS, Ng AW, Ong KC, Kaw GJ, Lee LS. Hypocortisolism in survivors of severe acute respiratory syndrome (SARS). Clin Endocrinol (Oxf) 2005; 63(2): 197–202
  3. Wei L, Sun S, Zhang J, Zhu H, Xu Y, Ma Q, et al. Endocrine cells of the adenohypophysis in severe acute respiratory syndrome (SARS). Biochem Cell Biol 2010; 88(4): 723–30
  4. Pal R, Banerjee M. COVID-19 and the endocrine system: Exploring the unexplored. J Endocrinol Invest 2020; 43(7): 1027–31
  5. Chang L, Yan Y, Wang L. Coronavirus disease 2019: Coronaviruses and blood safety. Transfus Med Rev 2020; 34(2): 75–80
  6. Ding Y, He L, Zhang Q, Huang Z, Che X, Hou J, et al. Organ distribution of severe acute respiratory syndrome (SARS) associated coronavirus (SARS-CoV) in SARS patients: Implications for pathogenesis and virus transmission pathways. J Pathol 2004; 203(2): 622–30
  7. Alzahrani AS, Mukhtar N, Aljomaiah A, Aljamei H, Bakhsh A, Alsudani N, et al. The impact of COVID-19 viral infection on the hypothalamic- pituitary-adrenal axis. Endocr Pract 2021; 27(2): 83–9.